Nuvation Bio Inc.
NUVB
$6.22
$0.121.97%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,264.35% | 114.75% | 34.41% | 5.45% | -10.84% |
| Total Depreciation and Amortization | 0.00% | -0.56% | 0.94% | 50.00% | 14.84% |
| Total Amortization of Deferred Charges | 9.03% | -1.83% | 3.15% | 1,661.11% | -- |
| Total Other Non-Cash Items | 133.16% | -15.94% | 14.56% | 4.37% | 36.09% |
| Change in Net Operating Assets | 55.98% | -83.24% | 27.52% | -4,562.37% | -92.97% |
| Cash from Operations | -947.68% | 117.05% | 43.78% | -9.78% | -13.02% |
| Capital Expenditure | -429.17% | 46.07% | -641.67% | 93.37% | -151.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 114.33% | -150.00% | 190.23% | -275.47% | 1.48% |
| Cash from Investing | 113.73% | -150.11% | 190.13% | -276.07% | 1.28% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -6,810.30% | 92.57% | -16,994.12% | 59.04% | 68.91% |
| Issuance of Common Stock | 422.91% | -89.30% | 1,420.79% | -56.91% | 19.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 100.17% | -- |
| Cash from Financing | 387,465.91% | -99.45% | 1,509.38% | -99.74% | 35,196.17% |
| Foreign Exchange rate Adjustments | -96.51% | 23.21% | -250.00% | 50.00% | -184.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 444.26% | -159.36% | 143.73% | -174.54% | 1,532.06% |